Mark Richard Schleiss MD
Professor, Pediatrics, University of Minnesota Medical School
Join to View Full Profile
2001 6th Street SE3rd FloorMinneapolis, MN 55455
Phone+1 612-624-1112
Fax+1 612-626-9924
Dr. Schleiss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Pediatric Infectious Diseases, 1988 - 1991
Oregon Health & Science University (OHSU Health)Residency, Pediatrics, 1985 - 1988
Oregon Health and Science University School of MedicineClass of 1985
Certifications & Licensure
MN State Medical License 2005 - 2025
OR State Medical License 1986 - 2025
OH State Medical License 1991 - 2006
WA State Medical License 1988 - 1991
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- Bicentennial Courier American Heritage, 1976
Publications & Presentations
PubMed
- Cytomegalovirus reactivation and acute and chronic complications in children with cerebral malaria: a prospective cohort study.Jonathan A Mayhew, Andrew J Witten, Caitlin A Bond, Robert O Opoka, Paul Bangirana
Malaria Journal. 2025-02-17 - An Unusual Soft-Tissue Infection in the "Land of 10,000 Lakes".Julia R Klein, Haejin Hwang, Marijke Decuir, Evann E Hilt, Mark R Schleiss
Clinical Pediatrics. 2025-01-30 - A vaccine against cytomegalovirus: how close are we?Sallie R Permar, Mark R Schleiss, Stanley A Plotkin
The Journal of Clinical Investigation. 2025-01-02
Press Mentions
Population-Based Screening Program Identifies and Manages Congenital Cytomegalovirus in Ontario NewbornsJanuary 22nd, 2025- CMV Screening: The Change in MN Affecting Every Newborn in the StateApril 5th, 2023
- Congenital Cytomegalovirus Declined in Wake of COVID-19September 13th, 2022
- Join now to see all
Grant Support
- Optimizing Immunity and Maternal Host Defense Against Congenital Cytomegalovirus InfectionUNIVERSITY OF MINNESOTA2019–2025
- If You Don't Pass, ScreenMinnesota Vikings CHIP Grant2016–2019
- Viral Immunomodulation And Rational CMV Vaccine DesignEunice Kennedy Shriver National Institute Of Child Health &Human Development2004–2012
- Bedside-To-Bench Research Training For Pediatric Infectious Diseases FellowsEunice Kennedy Shriver National Institute Of Child Health &Human Development2011
- Vaccines For Prevention Of Experimental Congenital CMVEunice Kennedy Shriver National Institute Of Child Health &Human Development2005–2009
- Transgenic Plant-Derived CMV Glycoprotein B VaccineNational Institute Of Allergy And Infectious Diseases2006–2007
- Novel Strategy For Animal Model Testing Of HCMV VaccinesNational Institute Of Allergy And Infectious Diseases2006–2007
- Viral Immunomodulation And Rational CMV Vaccine DesignEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2004
- Vaccines For Prevention Of Experimental Congenital CMVEunice Kennedy Shriver National Institute Of Child Health &Human Development2000–2003
- Gpcmv Structural/Regulatory Proteins--Molecular AnalysisNational Institute Of Allergy And Infectious Diseases1994–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
